Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes

Journal of the American College of Cardiology

Volumn 34, Issue 2, 1999, Pages 494-499

  Karjalainen, Jouko ^a   Kujala, Urho M ^b   Stolt, Anu ^b   Mäntysaari, Matti ^a   Viitasalo, Matti ^b   Kainulainen, Katariina ^b   Kontula, Kimmo ^b  

^a CENTRAL MILITARY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; ATHLETE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDURANCE; FEMALE; GENETIC VARIABILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANGIOTENSINOGEN; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PEPTIDYL-DIPEPTIDASE A; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN; SEX FACTORS; SPORTS;

EID: 0032752584     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00199-0     Document Type: Article

References (26)

1. Levy D., Anderson K.M., Savage D.D., et al. Echocardiographically detected left ventricular hypertrophy prevalence and risk factors: the Framingham Heart Study . Ann Intern Med. 108:1988;7-13.
2. Karjalainen J., Mäntysaari M., Viitasalo M., Kujala U. Left ventricular mass, geometry, and filling in endurance athletes association with exercise blood pressure . J Appl Physiol. 82:1997;531-537.
3. Maron B.J. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol. 7:1986;190-193.
4. Sadoshima J.-I., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
5. Lee Y.A., Liang C.S., Lee M.A., Lindpaintner K. Local stress, not systemic factors, regulates gene expression of the cardiac renin-angiotensin system in vivo a comprehensive study of all its components in the dog . Proc Natl Acad Sci USA. 93:1996;11035-11040.
6. Corvol P., Jeunemaitre X. Molecular genetics of human hypertension role of angiotensinogen . Endocr Rev. 18:1997;662-667.
7. Schunkert H., Hense H.-W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
8. Kupari M., Perola M., Koskinen P., et al. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol. 267:1994;H1107-H1111.
9. Kauma H., Ikäheimo M., Savolainen M.J., et al. Variants of renin-angiotensin system genes and echocardiographic left ventricular mass. Eur Heart J. 19:1998;1109-1117.
10. Iwai N., Shimoike H., Ohmichi N., Kinoshita M. Angiotensinogen gene and blood pressure in Japanese population. Hypertension. 25:1995;688-693.
11. Busjahn A., Knoblauch H., Knoblauch M., et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension. 29:1997;165-170.
12. Castellano M., Muiesan M.L., Beschi M., et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationship with blood pressure and cardiovascular structure. Hypertension. 28:1996;1076-1080.
13. Hamon M., Amant C., Bauters C., et al. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with ventricular function and mass in patients with angiographically normal coronary arteries. Heart. 77:1997;502-505.
14. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension. 9:(Suppl II):1987;19-26.
15. Rigat B., Hubert C., Corvol P., Soubrer F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucl Acid Res. 20:1992;251.
16. Shanmugan V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121.
17. Syvänen A.C., Aalto-Setälä K, Harju L., et al. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics. 8:1990;684-692.
18. Kiema T.-R., Kauma H., Rantala A.O., Savolainen M.J. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension. 28:1996;1070-1075.
19. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension. Role of angiotensinogen. Cell. 71:1992;169-180.
20. Montgomery H., Clarkson P., Dollery C.M., et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 96:1997;741-747.
21. Finkch M., Hellmann W., Ganten D., et al. Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats. Basic Res Cardiol. 86:1991;303-316.
22. Geenen D.L., Malhotra A., Scheuer J. Angiotensin II increases cardiac protein synthesis in adult rat heart. Am J Physiol. 265:1993;H238-H243.
23. Baker K.M., Aceto J.F. Angiotensin II stimulation of protein synthesis and cell growth in chick cells. Am J Physiol. 259:1990;H610-H618.
24. Molkentin J.D., Olson E.N. GATA4 a novel transcriptional regulator of cardiac hypertrophy . Circulation. 96:1997;3833-3835.
25. Harrap S.P., Dominiczak A.F., Fraser R., et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation. 93:1996;1148-1154.
26. Inoue I., Nakajima T., Williams C.S., et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 99:1997;1786-1797.